Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis 4503

Champion - 10+ consecutive years of dividend increases

Max Ratio

9.13

Dividend Yield

5.65 %

5Y Dividend Growth

85.00 %

Consecutive Years

13 years

5Y Average Payout Ratio

250.27 %

Dividend History 4503

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 5.65 %
Consecutive Years 13
Forward Annual Dividend 113.00 JPY
Consistent Years 22
Dividend CAGR 3Y 13.96 %
Continuous Dividends
Dividend CAGR 5Y 13.09 %
Payout Ratio TTM 83.86 %
Dividend CAGR 10Y 9.45 %
Ex Dividend Date 09/29/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth 4503

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin 4503

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income 4503

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM 4503

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio 4503

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Astellas Pharma Inc. 4503

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself 4503

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 28.63
Forward PE 12.35
Enterprise Value Revenue 1.99
Price Sales TTM 1.77
Enterprise Value EBITDA 11.51
Price Book MRQ 2.20

Astellas Pharma Inc. Dividends: 3.80 % Yield, History, Payment Schedule

4503
Current price
2 000.00 JPY +23.52 JPY (+1.19%)
Last closed 1 983.50 JPY
ISIN JP3942400007
Sector Healthcare
Industry Drug Manufacturers - General
Exchange Tokyo Stock Exchange
Capitalization 3 574 666 381 345 JPY
Yield for 12 month +25.55 %
1Y
3Y
5Y
10Y
15Y
4503
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+1 920 179 028 335 JPY

Last Year

+1 610 260 056 899 JPY

Current Quarter

+507 871 856 079 JPY

Last Quarter

+461 180 829 125 JPY

Current Year

+1 432 214 619 590 JPY

Last Year

+1 316 573 496 954 JPY

Current Quarter

+412 653 288 372 JPY

Last Quarter

+351 312 324 120 JPY
EBITDA 565 396 223 712 JPY
Operating Margin TTM 17.72 %
Price to Earnings 28.63
Return On Assets TTM 6.68 %
PEG Ratio
Return On Equity TTM 7.95 %
Wall Street Target Price 286 692.20 JPY
Revenue TTM 2 015 060 213 622 JPY
Book Value 903.88 JPY
Revenue Per Share TTM
Dividend Share 76.31 JPY
Quarterly Revenue Growth YOY 13.40 %
Dividend Yield 5.65 %
Gross Profit TTM 1 637 776 594 015 JPY
Earnings per share 69.71 JPY
Diluted Eps TTM 69.71 JPY
Most Recent Quarter II 2025
Quarterly Earnings Growth YOY 120.60 %
Profit Margin 6.22 %

Technical Indicators 4503

For 52 Weeks

1 218.99 JPY 2 008.22 JPY
50 Day MA 1 742.21 JPY
Shares Short Prior Month
200 Day MA 1 541.94 JPY
Short Ratio
Shares Short
Short Percent